Latest filing published 31 May 2023 for GeneDx Holdings Corp..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Shawn Assad: trading record in brief
All filings by Shawn Assad on record concern GeneDx Holdings Corp., in the capacity of senior executive. Between 25 October 2021 and 12 August 2022, the trades on record add up to 13 filings.
The open-market record consists of 5 sales worth €47k, with no purchase. Besides market trades, the filings include 2 share grants and 6 option exercises. In 2023 alone, the filings show no purchases and 2 sales.
On 31 May 2023 came the latest disclosure, an option exercise in GeneDx Holdings Corp. Typically, a trade is published a median of 5 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Shawn Assad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,139 sharesClass A Common StockSEC:0001209191-23-033108:0
- 10,457 sharesClass A Common StockSEC:0001209191-22-028698:0
- 10,457 sharesClass A Common StockSEC:0001209191-22-009575:0
- 249 shares@ US$6.05100.0% of flowClass A Common StockSEC:0001209191-21-067990:0
- 10,457 sharesClass A Common StockSEC:0001209191-21-064519:0
- 10,457 sharesClass A Common StockSEC:0001209191-21-062556:0
6 of 6 declarations
